Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and …
Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and
pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term …
pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term …
Autopsy findings and causality relationship between death and COVID-19 vaccination: a systematic review
F Sessa, M Salerno, M Esposito, N Di Nunno… - Journal of clinical …, 2021 - mdpi.com
The current challenge worldwide is the administration of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) vaccine. Considering that the COVID-19 vaccination …
syndrome coronavirus 2 (SARS-CoV-2) vaccine. Considering that the COVID-19 vaccination …
[HTML][HTML] A case report: multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19
M Mörz - Vaccines, 2022 - mdpi.com
Vaccines | Free Full-Text | A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis
after BNT162b2 mRNA Vaccination against COVID-19 Next Article in Journal Cross-National …
after BNT162b2 mRNA Vaccination against COVID-19 Next Article in Journal Cross-National …
[HTML][HTML] Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave
Cardiovascular adverse conditions are caused by coronavirus disease 2019 (COVID-19)
infections and reported as side-effects of the COVID-19 vaccines. Enriching current vaccine …
infections and reported as side-effects of the COVID-19 vaccines. Enriching current vaccine …
[HTML][HTML] Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States
D Montano - Frontiers in public health, 2022 - frontiersin.org
Introduction This study aims to provide a risk assessment of the adverse reactions related to
the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer …
the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer …
[HTML][HTML] Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
A case of fatal multi-organ inflammation following COVID-19 vaccination
H Nushida, A Ito, H Kurata, H Umemoto, I Tokunaga… - Legal Medicine, 2023 - Elsevier
A 14-year-old Japanese girl died unexpectedly 2 days after receiving the third dose of the
BNT1262b2 mRNA COVID-19 vaccine. Autopsy findings showed congestive edema of the …
BNT1262b2 mRNA COVID-19 vaccine. Autopsy findings showed congestive edema of the …
Increased interleukin 18-dependent immune responses are associated with myopericarditis after COVID-19 mRNA vaccination
Myocarditis and myopericarditis may occur after COVID-19 vaccination with an incidence of
two to twenty cases per 100,000 individuals, but underlying mechanisms related to disease …
two to twenty cases per 100,000 individuals, but underlying mechanisms related to disease …
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021
Clinical course and outcomes of myocarditis after COVID-19 vaccination remain variable.
We retrospectively collected data on patients> 12 years old from 01/01/2021 to 12/30/2021 …
We retrospectively collected data on patients> 12 years old from 01/01/2021 to 12/30/2021 …